FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical industry, specifically to use of a complex of water-soluble polysaccharides as an agent possessing immunomodulating activity, for inducing production of pro-inflammatory cytokines - interleukin-12, tumor necrosis factor-alpha by macrophages and interferon-gamma lymphocytes, inhibiting production of anti-inflammatory cytokines - interleukin-4 and interleukin-10 and stimulating an immune response caused by erythrocyte ram. Using a complex of water-soluble polysaccharides with molecular weights of 1053 kDa, 628 kDa and 35 kDa and their relative content of 61.24 wt. %; 5.37 wt. % and 33.39 wt. %, respectively, of duckweed separated from grass (Lemna polyrrhyza L.), as an agent exhibiting immunomodulatory activity, for inducing production of pro-inflammatory cytokines - interleukin-12, tumour necrosis factor-alpha by macrophages and interferon-gamma lymphocytes, inhibiting the production of anti-inflammatory cytokines - interleukin-4 and interleukin-10 and stimulating the immune response induced by erythrocytes of ram, wherein said polysaccharides are obtained by extraction for 3–4 hours of vegetal raw material, dried to air-dry state with moisture content less than 6 %, in a boiling water bath with purified water with addition of HCl pH = 4.0 in ratio of raw material: extractant - 1:20, filtration through the multilayer fabric filter, evaporation of filtrate to 1/5 of the initial volume on the rotary evaporator at a temperature of not more than 50 °C, settling for 24 h at temperature of 2–4 °C in triple volume of 96 % ethanol, filtration through a paper filter, dissolving the residue in purified water on a magnetic mixer for 3 hours at room temperature, removal of non-dissolved residue from fine particles of raw material and denatured protein by centrifugation for 30 minutes at 4000 rpm, dialysis through a semipermeable membrane with pore diameter of 15 kDa for 48 hours in 50-fold volume of purified water at room temperature and stirring on a magnetic mixer with water change after 24 hours, dialysate freezing and lyophilic drying.
EFFECT: above complex of water-soluble polysaccharides is an activator of inflammatory properties of macrophages and Th1-dependent type of immune response, possesses pronounced immunomodulatory activity, for inducing production of pro-inflammatory cytokines - interleukin-12, tumour necrosis factor-alpha by macrophages and interferon-gamma lymphocytes, inhibiting production of anti-inflammatory cytokines - interleukin-4 and interleukin-10 and stimulating an immune response caused by erythrocyte ram.
1 cl, 6 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
MEANS OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2657819C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY | 2018 |
|
RU2697526C1 |
HUMIC SUBSTANCE HAVING IMMUNOMODULATORY ACTIVITY | 2019 |
|
RU2716504C1 |
AGENT OF HUMIC NATURE OF IMMUNOMODULATING ACTIVITY | 2017 |
|
RU2662094C1 |
IMMUNOMODULATORY DRUG | 2011 |
|
RU2470656C1 |
IMMUNOMODULATORY DRUG | 2010 |
|
RU2421232C1 |
MEDICATION POSSESSING IMMUNOMODULATING ACTIVITY | 2010 |
|
RU2423141C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2329821C1 |
AGENT OF IMMUNOMODULATING ACTIVITY | 2007 |
|
RU2337700C1 |
DRUG OF HUMIC NATURE, WHICH HAS AN IMMUNOMODULATORY EFFECT | 2022 |
|
RU2783772C1 |
Authors
Dates
2020-10-16—Published
2019-06-13—Filed